| Symbol | SEPSF |
|---|---|
| Name | ASEP MEDICAL HOLDINGS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V8W 3Y7 Canada BC 420 - 730 View Street |
| Telephone | +1 778-600-0509 |
| Fax | — |
| — | |
| Website | http://www.asepmedical.com/ |
| Incorporation | CA |
| Incorporated On | 2021 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Manning Elliott LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | 0001969766 |
| Description | Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. The Company is a consolidation of three existing private companies, all with technology in advanced development - Sepset Biosciences Inc. (proprietary diagnostic tools to enable the early and timely identification of sepsis), ABT Innovations Inc. (broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections), and SafeCoat Medical Inc. (an antibacterial peptide medical device coating technology). Additional info from OTC: |
No news found.